Sarepta Therapeutics (SRPT) Price Target Lowered by JP Morgan | SRPT Stock News - GuruFocus
2 hours ago • Google News
Sarepta Therapeutics Inc (SRPT)
US$ 36.433.29%
Price Chart
Key Statistics
Market Cap
$ 3.73B
P/E Ratio
0.00
Revenue (TTM)
$ 2.23B
Volume
3.98M
52W High
$ 173.25
52W Low
$ 34.10
Dividend Yield
0.00%
Beta
0.84
Technicals
50-Day MA
61.7008
200-Day MA
107.4654
52 Week High
173.25
52 Week Low
34.1
About SRPT
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalitie.
Employees
1372
Headquarters
Cambridge, MA
CEO
Mr. Douglas S. Ingram Esq.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg